Contrasting Epstein–Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design
- 22 June 2001
- Vol. 19 (27) , 3769-3777
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cost-Efficient Quantification of Enzyme-Linked ImmunospotBioTechniques, 2001
- Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytesEuropean Journal of Immunology, 1998
- Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 geneTrends in Microbiology, 1997
- Rapid Effector Function in CD8+ Memory T CellsJournal of Experimental Medicine, 1997
- HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTIONAnnual Review of Immunology, 1997
- Isolation of Cytotoxic T Lymphocytes from Healthy Seropositive Individuals Specific for Peptide Epitopes from Epstein–Barr Virus Nuclear Antigen 1: Implications for Viral Persistence and Tumor Surveillance1Virology, 1995
- Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.Journal of Experimental Medicine, 1992
- Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.Journal of Experimental Medicine, 1992
- Cytotoxic T lymphocyte discrimination between type A Epstein--Barr virus transformants is mapped to an immunodominant epitope in EBNA 3Journal of General Virology, 1991
- Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformantsNature, 1988